Viewing Study NCT05728268


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2025-12-26 @ 3:25 PM
Study NCT ID: NCT05728268
Status: UNKNOWN
Last Update Posted: 2023-02-15
First Post: 2023-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index
Sponsor: Shantou Central Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module